[1]
P. Gupta, “Potential benefits of novel agent Tanshinone in the management of oral submucous fibrosis”, J Orofac Res, vol. 9, no. 2, pp. 20–23, May 2020, Accessed: Dec. 05, 2025. [Online]. Available: https://www.mansapublishers.com/jofr/article/view/2321